Next Article in Journal
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
Previous Article in Journal
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience
Previous Article in Special Issue
Proteome-Wide Identification of RNA-Dependent Proteins in Lung Cancer Cells
 
 
Review

Article Versions Notes

Cancers 2023, 15(4), 1150; https://doi.org/10.3390/cancers15041150
Action Date Notes Link
article pdf uploaded. 10 February 2023 15:40 CET Version of Record https://www.mdpi.com/2072-6694/15/4/1150/pdf-vor
article xml file uploaded 13 February 2023 07:14 CET Original file -
article xml uploaded. 13 February 2023 07:14 CET Update https://www.mdpi.com/2072-6694/15/4/1150/xml
article pdf uploaded. 13 February 2023 07:14 CET Updated version of record https://www.mdpi.com/2072-6694/15/4/1150/pdf
article html file updated 13 February 2023 07:15 CET Original file -
article html file updated 1 March 2023 13:49 CET Update https://www.mdpi.com/2072-6694/15/4/1150/html
Back to TopTop